Login

Krux Analytics optimizes drilling activities and costs to maximize meters drilled in drill programs.|Jody Conrad Chief Executive Officer of Krux Analytics 00:10:00

Share On Facebook Share On Twitter

Jody Conrad, Founder & CEO, Krux Analytics

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Cultivating Trust and Continuous Learning: A Conversation with Stan Moss, CEO of Poland Capital | Stan Moss, CEO, Poland Capital.
00:10:00
Hear from Moneysupermarket Group's Chief Technical & Product Officer about the achievements across their tech, product, and design teams over the busy year.
00:10:00
Romeo's Gold Resources: Exploring BC's Golden Triangle
00:10:00
Clarent Precision: The Key to Success in Quality Machining and Customer Satisfaction
00:10:00
Zynerba Pharmaceuticals Bolsters IP Portfolio for Zygel, Revolutionary Cannabidiol Clear Gel with Enhanced Transdermal Delivery| ARMANDO ANIDO , CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER OF ZYNERBA PHARMACEUTICALS, INC
00:10:00
Embracing Retirement: Leveraging Skills and Flexibility in the Gig Economy
00:10:00
11 bit studios' Future: Insights on Frostpunk 2, Project 8, and XDev with President Przemyslaw Marszal | Przemyslaw Marszal, CEO , 11 bit studio Inc.
00:10:00
Jean-Claude Maurel Shares Optimism and Insights on Enhancing SME Financing | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
The Book of Mormon: Dialogic Revelation and Christian Beliefs in the Western Hemispher|Terryl Givens,Professor,University of Richmond
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Introduction to Orla Mining: Projects, Team, and Future Plans
00:10:00
Nuvos Therapeutics: Advancing Oxygen Nanobubble Therapy with Breakthrough Phase 2B Programs in Oncology, Stroke, and Respiratory Distress|Evan Unger,MD,NuvOx Therapeutics

© 2026 Nehu